[Federal Register Volume 64, Number 162 (Monday, August 23, 1999)]
[Notices]
[Page 45971]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-21775]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Clinical Laboratory Improvement Advisory Committee (CLIAC): 
Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meetings.

    Name: Clinical Laboratory Improvement Advisory Committee 
(CLIAC).
    Times and Dates: 8:30 a.m-5 p.m., September 22, 1999. 8:30 a.m.-
3:30 p.m., September 23, 1999.
    Place: CDC, Koger Center, Williams Building, Conference Rooms 
1802 and 1805, 2877 Brandywine Road, Atlanta, Georgia 30341.
    Status: Open to the public, limited only by the space available. 
The meeting rooms accommodate approximately 85 people.
    Purpose: This committee is charged with providing scientific and 
technical advice and guidance to the Secretary of Health and Human 
Services, the Assistant Secretary for Health, and the Director, CDC, 
regarding the need for, and the nature of, revisions to the 
standards under which clinical laboratories are regulated; the 
impact of proposed revisions to the standards; and the modification 
of the standards to accommodate technological advances.
    Matters To Be Discussed: The agenda will include an update on 
CLIA implementation; presentations of data and discussion of 
laboratory workforce issues, including potential shortages of 
qualified laboratory personnel and the education/skill levels of 
current personnel.
    The Committee solicits oral and written testimony on the 
laboratory workforce issues of potential shortages of qualified 
laboratory personnel and the education/skill levels of current 
personnel. Requests to make an oral presentation should be submitted 
in writing to the contact person listed below by close of business, 
September 16, 1999. All requests to make oral comments should 
contain the name, address, telephone number, and organizational 
affiliation of the presenter. Written comments should not exceed 
five single-spaced typed pages in length and should be received by 
the contact person listed below by close of business, September 16, 
1999.

    Agenda items are subject to change as priorities dictate.
    Contact Person for Additional Information: John C. Ridderhof, 
Dr.P.H., Division of Laboratory Systems, Public Health Practice Program 
Office, CDC, 4770 Buford Highway, NE, M/S G-25, Atlanta, Georgia 30341-
3724, telephone 770/488-8076, FAX 770/488-8282.
    The Director, Management and Analysis and Services office has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

    Dated: August 16, 1999.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 99-21775 Filed 8-20-99; 8:45 am]
BILLING CODE 4163-18-P